 | • レポートコード：QFJ1-5028 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、バーチャル臨床試験の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（介入試験、観察試験、拡張参加試験）、用途別市場規模（腫瘍、循環器疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・バーチャル臨床試験の市場動向 ・企業の競争状況、市場シェア ・バーチャル臨床試験の種類別市場規模と予測2016-2027（介入試験、観察試験、拡張参加試験） ・バーチャル臨床試験の用途別市場規模と予測2016-2027（腫瘍、循環器疾患、その他） ・バーチャル臨床試験の北米市場規模2016-2027（アメリカ、カナダ） ・バーチャル臨床試験の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・バーチャル臨床試験のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・バーチャル臨床試験の中南米市場規模2016-2027（メキシコ、ブラジル） ・バーチャル臨床試験の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（ICON Plc、LEO Innovation Lab、Science 37、PRA Health Sciences、Clinical Ink、Parexel、Medable、Oracle、CRF Health、Medidata、Covance、IQVIA） ・結論 |
Virtual Clinical Trials (VCTs), also called remote or decentralized trials, are a relatively new and yet underutilized method of conducting clinical research taking full advantage of technologies such as apps, electronic monitoring devices, and online social engagement platforms.
Virtual clinical trials (VCT) eliminate challenges posed by traditional clinical trials such as time-consuming procedures and delay in patient recruitment that has driven the demand for the virtual clinical trial market. Moreover, technological advancements in healthcare infrastructure and alliances between biotechnology, pharmaceutical & clinical research organization are anticipated to boost the virtual clinical trials market growth in the near future.
Market Analysis and Insights: Global Virtual Clinical Trials Market
The global Virtual Clinical Trials market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Virtual Clinical Trials market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Virtual Clinical Trials market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Virtual Clinical Trials market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Virtual Clinical Trials market.
Global Virtual Clinical Trials Scope and Market Size
Virtual Clinical Trials market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Virtual Clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Interventional Trials
Observational Trials
Expanded Access Trials
Segment by Application
Oncology
Cardiovascular Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
ICON Plc
LEO Innovation Lab
Science 37
PRA Health Sciences
Clinical Ink
Parexel
Medable
Oracle
CRF Health
Medidata
Covance
IQVIA
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Virtual Clinical Trials Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Interventional Trials
1.2.3 Observational Trials
1.2.4 Expanded Access Trials
1.3 Market by Application
1.3.1 Global Virtual Clinical Trials Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology
1.3.3 Cardiovascular Disease
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Virtual Clinical Trials Market Perspective (2016-2027)
2.2 Virtual Clinical Trials Growth Trends by Regions
2.2.1 Virtual Clinical Trials Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Virtual Clinical Trials Historic Market Share by Regions (2016-2021)
2.2.3 Virtual Clinical Trials Forecasted Market Size by Regions (2022-2027)
2.3 Virtual Clinical Trials Industry Dynamic
2.3.1 Virtual Clinical Trials Market Trends
2.3.2 Virtual Clinical Trials Market Drivers
2.3.3 Virtual Clinical Trials Market Challenges
2.3.4 Virtual Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Virtual Clinical Trials Players by Revenue
3.1.1 Global Top Virtual Clinical Trials Players by Revenue (2016-2021)
3.1.2 Global Virtual Clinical Trials Revenue Market Share by Players (2016-2021)
3.2 Global Virtual Clinical Trials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Virtual Clinical Trials Revenue
3.4 Global Virtual Clinical Trials Market Concentration Ratio
3.4.1 Global Virtual Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Virtual Clinical Trials Revenue in 2020
3.5 Virtual Clinical Trials Key Players Head office and Area Served
3.6 Key Players Virtual Clinical Trials Product Solution and Service
3.7 Date of Enter into Virtual Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Virtual Clinical Trials Breakdown Data by Type
4.1 Global Virtual Clinical Trials Historic Market Size by Type (2016-2021)
4.2 Global Virtual Clinical Trials Forecasted Market Size by Type (2022-2027)
5 Virtual Clinical Trials Breakdown Data by Application
5.1 Global Virtual Clinical Trials Historic Market Size by Application (2016-2021)
5.2 Global Virtual Clinical Trials Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Virtual Clinical Trials Market Size (2016-2027)
6.2 North America Virtual Clinical Trials Market Size by Type
6.2.1 North America Virtual Clinical Trials Market Size by Type (2016-2021)
6.2.2 North America Virtual Clinical Trials Market Size by Type (2022-2027)
6.2.3 North America Virtual Clinical Trials Market Size by Type (2016-2027)
6.3 North America Virtual Clinical Trials Market Size by Application
6.3.1 North America Virtual Clinical Trials Market Size by Application (2016-2021)
6.3.2 North America Virtual Clinical Trials Market Size by Application (2022-2027)
6.3.3 North America Virtual Clinical Trials Market Size by Application (2016-2027)
6.4 North America Virtual Clinical Trials Market Size by Country
6.4.1 North America Virtual Clinical Trials Market Size by Country (2016-2021)
6.4.2 North America Virtual Clinical Trials Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Virtual Clinical Trials Market Size (2016-2027)
7.2 Europe Virtual Clinical Trials Market Size by Type
7.2.1 Europe Virtual Clinical Trials Market Size by Type (2016-2021)
7.2.2 Europe Virtual Clinical Trials Market Size by Type (2022-2027)
7.2.3 Europe Virtual Clinical Trials Market Size by Type (2016-2027)
7.3 Europe Virtual Clinical Trials Market Size by Application
7.3.1 Europe Virtual Clinical Trials Market Size by Application (2016-2021)
7.3.2 Europe Virtual Clinical Trials Market Size by Application (2022-2027)
7.3.3 Europe Virtual Clinical Trials Market Size by Application (2016-2027)
7.4 Europe Virtual Clinical Trials Market Size by Country
7.4.1 Europe Virtual Clinical Trials Market Size by Country (2016-2021)
7.4.2 Europe Virtual Clinical Trials Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Virtual Clinical Trials Market Size (2016-2027)
8.2 Asia-Pacific Virtual Clinical Trials Market Size by Type
8.2.1 Asia-Pacific Virtual Clinical Trials Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Virtual Clinical Trials Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Virtual Clinical Trials Market Size by Type (2016-2027)
8.3 Asia-Pacific Virtual Clinical Trials Market Size by Application
8.3.1 Asia-Pacific Virtual Clinical Trials Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Virtual Clinical Trials Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Virtual Clinical Trials Market Size by Application (2016-2027)
8.4 Asia-Pacific Virtual Clinical Trials Market Size by Region
8.4.1 Asia-Pacific Virtual Clinical Trials Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Virtual Clinical Trials Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Virtual Clinical Trials Market Size (2016-2027)
9.2 Latin America Virtual Clinical Trials Market Size by Type
9.2.1 Latin America Virtual Clinical Trials Market Size by Type (2016-2021)
9.2.2 Latin America Virtual Clinical Trials Market Size by Type (2022-2027)
9.2.3 Latin America Virtual Clinical Trials Market Size by Type (2016-2027)
9.3 Latin America Virtual Clinical Trials Market Size by Application
9.3.1 Latin America Virtual Clinical Trials Market Size by Application (2016-2021)
9.3.2 Latin America Virtual Clinical Trials Market Size by Application (2022-2027)
9.3.3 Latin America Virtual Clinical Trials Market Size by Application (2016-2027)
9.4 Latin America Virtual Clinical Trials Market Size by Country
9.4.1 Latin America Virtual Clinical Trials Market Size by Country (2016-2021)
9.4.2 Latin America Virtual Clinical Trials Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Virtual Clinical Trials Market Size (2016-2027)
10.2 Middle East & Africa Virtual Clinical Trials Market Size by Type
10.2.1 Middle East & Africa Virtual Clinical Trials Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Virtual Clinical Trials Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Virtual Clinical Trials Market Size by Type (2016-2027)
10.3 Middle East & Africa Virtual Clinical Trials Market Size by Application
10.3.1 Middle East & Africa Virtual Clinical Trials Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Virtual Clinical Trials Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Virtual Clinical Trials Market Size by Application (2016-2027)
10.4 Middle East & Africa Virtual Clinical Trials Market Size by Country
10.4.1 Middle East & Africa Virtual Clinical Trials Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Virtual Clinical Trials Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 ICON Plc
11.1.1 ICON Plc Company Details
11.1.2 ICON Plc Business Overview
11.1.3 ICON Plc Virtual Clinical Trials Introduction
11.1.4 ICON Plc Revenue in Virtual Clinical Trials Business (2016-2021)
11.1.5 ICON Plc Recent Development
11.2 LEO Innovation Lab
11.2.1 LEO Innovation Lab Company Details
11.2.2 LEO Innovation Lab Business Overview
11.2.3 LEO Innovation Lab Virtual Clinical Trials Introduction
11.2.4 LEO Innovation Lab Revenue in Virtual Clinical Trials Business (2016-2021)
11.2.5 LEO Innovation Lab Recent Development
11.3 Science 37
11.3.1 Science 37 Company Details
11.3.2 Science 37 Business Overview
11.3.3 Science 37 Virtual Clinical Trials Introduction
11.3.4 Science 37 Revenue in Virtual Clinical Trials Business (2016-2021)
11.3.5 Science 37 Recent Development
11.4 PRA Health Sciences
11.4.1 PRA Health Sciences Company Details
11.4.2 PRA Health Sciences Business Overview
11.4.3 PRA Health Sciences Virtual Clinical Trials Introduction
11.4.4 PRA Health Sciences Revenue in Virtual Clinical Trials Business (2016-2021)
11.4.5 PRA Health Sciences Recent Development
11.5 Clinical Ink
11.5.1 Clinical Ink Company Details
11.5.2 Clinical Ink Business Overview
11.5.3 Clinical Ink Virtual Clinical Trials Introduction
11.5.4 Clinical Ink Revenue in Virtual Clinical Trials Business (2016-2021)
11.5.5 Clinical Ink Recent Development
11.6 Parexel
11.6.1 Parexel Company Details
11.6.2 Parexel Business Overview
11.6.3 Parexel Virtual Clinical Trials Introduction
11.6.4 Parexel Revenue in Virtual Clinical Trials Business (2016-2021)
11.6.5 Parexel Recent Development
11.7 Medable
11.7.1 Medable Company Details
11.7.2 Medable Business Overview
11.7.3 Medable Virtual Clinical Trials Introduction
11.7.4 Medable Revenue in Virtual Clinical Trials Business (2016-2021)
11.7.5 Medable Recent Development
11.8 Oracle
11.8.1 Oracle Company Details
11.8.2 Oracle Business Overview
11.8.3 Oracle Virtual Clinical Trials Introduction
11.8.4 Oracle Revenue in Virtual Clinical Trials Business (2016-2021)
11.8.5 Oracle Recent Development
11.9 CRF Health
11.9.1 CRF Health Company Details
11.9.2 CRF Health Business Overview
11.9.3 CRF Health Virtual Clinical Trials Introduction
11.9.4 CRF Health Revenue in Virtual Clinical Trials Business (2016-2021)
11.9.5 CRF Health Recent Development
11.10 Medidata
11.10.1 Medidata Company Details
11.10.2 Medidata Business Overview
11.10.3 Medidata Virtual Clinical Trials Introduction
11.10.4 Medidata Revenue in Virtual Clinical Trials Business (2016-2021)
11.10.5 Medidata Recent Development
11.11 Covance
11.11.1 Covance Company Details
11.11.2 Covance Business Overview
11.11.3 Covance Virtual Clinical Trials Introduction
11.11.4 Covance Revenue in Virtual Clinical Trials Business (2016-2021)
11.11.5 Covance Recent Development
11.12 IQVIA
11.12.1 IQVIA Company Details
11.12.2 IQVIA Business Overview
11.12.3 IQVIA Virtual Clinical Trials Introduction
11.12.4 IQVIA Revenue in Virtual Clinical Trials Business (2016-2021)
11.12.5 IQVIA Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Virtual Clinical Trials Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Interventional Trials
Table 3. Key Players of Observational Trials
Table 4. Key Players of Expanded Access Trials
Table 5. Global Virtual Clinical Trials Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Virtual Clinical Trials Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Virtual Clinical Trials Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Virtual Clinical Trials Market Share by Regions (2016-2021)
Table 9. Global Virtual Clinical Trials Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Virtual Clinical Trials Market Share by Regions (2022-2027)
Table 11. Virtual Clinical Trials Market Trends
Table 12. Virtual Clinical Trials Market Drivers
Table 13. Virtual Clinical Trials Market Challenges
Table 14. Virtual Clinical Trials Market Restraints
Table 15. Global Virtual Clinical Trials Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Virtual Clinical Trials Market Share by Players (2016-2021)
Table 17. Global Top Virtual Clinical Trials Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Virtual Clinical Trials as of 2020)
Table 18. Ranking of Global Top Virtual Clinical Trials Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Virtual Clinical Trials Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Virtual Clinical Trials Product Solution and Service
Table 22. Date of Enter into Virtual Clinical Trials Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Virtual Clinical Trials Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Virtual Clinical Trials Revenue Market Share by Type (2016-2021)
Table 26. Global Virtual Clinical Trials Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Virtual Clinical Trials Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Virtual Clinical Trials Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Virtual Clinical Trials Revenue Market Share by Application (2016-2021)
Table 30. Global Virtual Clinical Trials Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Virtual Clinical Trials Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Virtual Clinical Trials Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Virtual Clinical Trials Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Virtual Clinical Trials Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Virtual Clinical Trials Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Virtual Clinical Trials Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Virtual Clinical Trials Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Virtual Clinical Trials Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Virtual Clinical Trials Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Virtual Clinical Trials Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Virtual Clinical Trials Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Virtual Clinical Trials Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Virtual Clinical Trials Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Virtual Clinical Trials Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Virtual Clinical Trials Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Virtual Clinical Trials Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Virtual Clinical Trials Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Virtual Clinical Trials Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Virtual Clinical Trials Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Virtual Clinical Trials Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Virtual Clinical Trials Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Virtual Clinical Trials Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Virtual Clinical Trials Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Virtual Clinical Trials Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Virtual Clinical Trials Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Virtual Clinical Trials Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Virtual Clinical Trials Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Virtual Clinical Trials Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Virtual Clinical Trials Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Virtual Clinical Trials Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Virtual Clinical Trials Market Size by Country (2022-2027) & (US$ Million)
Table 62. ICON Plc Company Details
Table 63. ICON Plc Business Overview
Table 64. ICON Plc Virtual Clinical Trials Product
Table 65. ICON Plc Revenue in Virtual Clinical Trials Business (2016-2021) & (US$ Million)
Table 66. ICON Plc Recent Development
Table 67. LEO Innovation Lab Company Details
Table 68. LEO Innovation Lab Business Overview
Table 69. LEO Innovation Lab Virtual Clinical Trials Product
Table 70. LEO Innovation Lab Revenue in Virtual Clinical Trials Business (2016-2021) & (US$ Million)
Table 71. LEO Innovation Lab Recent Development
Table 72. Science 37 Company Details
Table 73. Science 37 Business Overview
Table 74. Science 37 Virtual Clinical Trials Product
Table 75. Science 37 Revenue in Virtual Clinical Trials Business (2016-2021) & (US$ Million)
Table 76. Science 37 Recent Development
Table 77. PRA Health Sciences Company Details
Table 78. PRA Health Sciences Business Overview
Table 79. PRA Health Sciences Virtual Clinical Trials Product
Table 80. PRA Health Sciences Revenue in Virtual Clinical Trials Business (2016-2021) & (US$ Million)
Table 81. PRA Health Sciences Recent Development
Table 82. Clinical Ink Company Details
Table 83. Clinical Ink Business Overview
Table 84. Clinical Ink Virtual Clinical Trials Product
Table 85. Clinical Ink Revenue in Virtual Clinical Trials Business (2016-2021) & (US$ Million)
Table 86. Clinical Ink Recent Development
Table 87. Parexel Company Details
Table 88. Parexel Business Overview
Table 89. Parexel Virtual Clinical Trials Product
Table 90. Parexel Revenue in Virtual Clinical Trials Business (2016-2021) & (US$ Million)
Table 91. Parexel Recent Development
Table 92. Medable Company Details
Table 93. Medable Business Overview
Table 94. Medable Virtual Clinical Trials Product
Table 95. Medable Revenue in Virtual Clinical Trials Business (2016-2021) & (US$ Million)
Table 96. Medable Recent Development
Table 97. Oracle Company Details
Table 98. Oracle Business Overview
Table 99. Oracle Revenue in Virtual Clinical Trials Business (2016-2021) & (US$ Million)
Table 100. Oracle Recent Development
Table 101. CRF Health Company Details
Table 102. CRF Health Business Overview
Table 103. CRF Health Virtual Clinical Trials Product
Table 104. CRF Health Revenue in Virtual Clinical Trials Business (2016-2021) & (US$ Million)
Table 105. CRF Health Recent Development
Table 106. Medidata Company Details
Table 107. Medidata Business Overview
Table 108. Medidata Virtual Clinical Trials Product
Table 109. Medidata Revenue in Virtual Clinical Trials Business (2016-2021) & (US$ Million)
Table 110. Medidata Recent Development
Table 111. Covance Company Details
Table 112. Covance Business Overview
Table 113. Covance Virtual Clinical Trials Product
Table 114. Covance Revenue in Virtual Clinical Trials Business (2016-2021) & (US$ Million)
Table 115. Covance Recent Development
Table 116. IQVIA Company Details
Table 117. IQVIA Business Overview
Table 118. IQVIA Virtual Clinical Trials Product
Table 119. IQVIA Revenue in Virtual Clinical Trials Business (2016-2021) & (US$ Million)
Table 120. IQVIA Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Virtual Clinical Trials Market Share by Type: 2020 VS 2027
Figure 2. Interventional Trials Features
Figure 3. Observational Trials Features
Figure 4. Expanded Access Trials Features
Figure 5. Global Virtual Clinical Trials Market Share by Application: 2020 VS 2027
Figure 6. Oncology Case Studies
Figure 7. Cardiovascular Disease Case Studies
Figure 8. Others Case Studies
Figure 9. Virtual Clinical Trials Report Years Considered
Figure 10. Global Virtual Clinical Trials Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Virtual Clinical Trials Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Virtual Clinical Trials Market Share by Regions: 2020 VS 2027
Figure 13. Global Virtual Clinical Trials Market Share by Regions (2022-2027)
Figure 14. Global Virtual Clinical Trials Market Share by Players in 2020
Figure 15. Global Top Virtual Clinical Trials Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Virtual Clinical Trials as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Virtual Clinical Trials Revenue in 2020
Figure 17. Global Virtual Clinical Trials Revenue Market Share by Type (2016-2021)
Figure 18. Global Virtual Clinical Trials Revenue Market Share by Type (2022-2027)
Figure 19. North America Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Virtual Clinical Trials Market Share by Type (2016-2027)
Figure 21. North America Virtual Clinical Trials Market Share by Application (2016-2027)
Figure 22. North America Virtual Clinical Trials Market Share by Country (2016-2027)
Figure 23. United States Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Virtual Clinical Trials Market Share by Type (2016-2027)
Figure 27. Europe Virtual Clinical Trials Market Share by Application (2016-2027)
Figure 28. Europe Virtual Clinical Trials Market Share by Country (2016-2027)
Figure 29. Germany Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Virtual Clinical Trials Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Virtual Clinical Trials Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Virtual Clinical Trials Market Share by Region (2016-2027)
Figure 39. China Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Virtual Clinical Trials Market Share by Type (2016-2027)
Figure 47. Latin America Virtual Clinical Trials Market Share by Application (2016-2027)
Figure 48. Latin America Virtual Clinical Trials Market Share by Country (2016-2027)
Figure 49. Mexico Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Virtual Clinical Trials Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Virtual Clinical Trials Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Virtual Clinical Trials Market Share by Country (2016-2027)
Figure 55. Turkey Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Virtual Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. ICON Plc Revenue Growth Rate in Virtual Clinical Trials Business (2016-2021)
Figure 59. LEO Innovation Lab Revenue Growth Rate in Virtual Clinical Trials Business (2016-2021)
Figure 60. Science 37 Revenue Growth Rate in Virtual Clinical Trials Business (2016-2021)
Figure 61. PRA Health Sciences Revenue Growth Rate in Virtual Clinical Trials Business (2016-2021)
Figure 62. Clinical Ink Revenue Growth Rate in Virtual Clinical Trials Business (2016-2021)
Figure 63. Parexel Revenue Growth Rate in Virtual Clinical Trials Business (2016-2021)
Figure 64. Medable Revenue Growth Rate in Virtual Clinical Trials Business (2016-2021)
Figure 65. Oracle Revenue Growth Rate in Virtual Clinical Trials Business (2016-2021)
Figure 66. CRF Health Revenue Growth Rate in Virtual Clinical Trials Business (2016-2021)
Figure 67. Medidata Revenue Growth Rate in Virtual Clinical Trials Business (2016-2021)
Figure 68. Covance Revenue Growth Rate in Virtual Clinical Trials Business (2016-2021)
Figure 69. IQVIA Revenue Growth Rate in Virtual Clinical Trials Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の膀胱がん臨床試験市場規模・現状・予測（2021年-2027年） Bladder Cancer Clinical trials are research studies that involve people. The clinical trials on this list are for bladder cancer treatment. ... This randomized phase III trial studies how well pembrolizumab works in treating patients with bladder cancer that has spread from where it started to nearb…- 世界の嚢胞性浮腫臨床試験市場規模・現状・予測（2021年-2027年） Macular edema is the accumulation of fluid in the macular retina or under the retina. Macular edema is an important cause of vision loss.Diabetic macular edema is a common ocular complication of diabetes.It causes blood vessels in the retina at the back of the eye to leak, causing swelling. Market A…
- 世界の臨床試験におけるCRO市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global CRO in Clinical Trials Market The global CRO in Clinical Trials market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…
- 世界の浮腫臨床試験市場規模・現状・予測（2021年-2027年） Edema refers to the body's tissues clearance with the accumulation of excess fluid organizational swelling.Edema can be divided into systemic and local.Systemic edema (usually pitting) occurs when fluid is distributed diffusely between tissues in the body.Fluid accumulation in local interstitial spa…
- 世界の糖原病（GSD）臨床試験市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Glycogen Storage Disorders (GSD) Clinical Trials Market The global Glycogen Storage Disorders (GSD) Clinical Trials market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard ac…